C-kit and PDGFRA gene mutations in triple negative breast cancer

被引：1

作者：

Zhu, Yun ^{[1
]}

Wang, Yan ^{[3
]}

Guan, Bing ^{[1
]}

Rao, Qiu ^{[1
]}

Wang, Jiandong ^{[1
]}

Ma, Henghui ^{[1
]}

Zhang, Zhihong ^{[2
]}

Zhou, Xiaojun ^{[1
]}

机构：

[1] Nanjing Univ, Nanjing Jinling Hosp, Coll Med, Dept Pathol,Clin Sch, Nanjing 210002, Jiangsu, Peoples R China

[2] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R China

[3] Nanjing Med Univ, Affiliated Hosp 2, Dept Pathol, Nanjing 210003, Jiangsu, Peoples R China

来源：

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2014年 / 7卷 / 07期

关键词：

C-KIT; PDGFRA; mutation; triple negative breast cancer; immunohistochemical expression; GASTROINTESTINAL STROMAL TUMORS; CELL LUNG-CANCER; KINASE INHIBITOR; EXPRESSION; CARCINOMAS; DASATINIB; RECEPTOR; GROWTH; LINES;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In this study, we evaluated C-kit immunohistochemical expression and C-kit and platelet derived growth factor receptor A (PDGFRA) gene mutations in triple negative breast cancer. 171 cases were analyzed by immunohistochemical staining for the expression of C-kit and 45 cases, including 10 C-kit negative cases and 35 C-kit positive cases, were performed for C-kit gene mutations in exons 9, 11, 13 and 17 and PDGFRA gene mutations in exons 12 and 18. C-kit expression was detected in 42.1% of triple negative breast cancers. Only 1 activating mutation was detected in exon 11 of C-kit gene in 1 case. No activating mutations were found in the other 44 cases. C-kit expression is a frequent finding in triple negative breast cancers; 1 activating mutation which was also found in gastrointestinal stromal tumors was detected; a few cases might benefit from imatinib.

引用

页码：4280 / 4285

页数：6

共 50 条

[31] c-kit gene mutations in adenoid cystic carcinoma are rare
Moskaluk, Christopher A.
Frierson, Henry F., Jr.
El-Naggar, Adel K.
Futreal, P. Andrew
MODERN PATHOLOGY, 2010, 23 (06) : 905 - 906
[32] c-Kit gene mutations in intracranial germ cell tumors
Steiger, B.
Schmidt, O.
Pietsch, T.
KLINISCHE PADIATRIE, 2010, 222 (03): : 221 - 221
[33] The diagnosis of C-kit negative GIST by PDGFRA staining: Clinical, pathological, and nuclear medicine perspective
Sevinc, Alper
Camci, Celalettin
Yilmaz, Mustafa
Buyukhatipoglu, Hakan
ONKOLOGIE, 2007, 30 (12): : 645 - 648
[34] Molecular analysis of c-Kit and PDGFRA in GISTs diagnosed by EUS
Gomes, Ana L.
Bardales, Ricardo H.
Milanezi, Fernanda
Reis, Rui M.
Schmitt, Fernando
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (01) : 89 - 96
[35] The molecular pathology characteristics of c-Kit and PDGFRA gene mutation in gastrointestinal stromal tumors in China
Zhang, B.
ANNALS OF ONCOLOGY, 2016, 27 : 55 - 55
[36] c-kit: identification of coregulated genes in breast cancer patients by gene expression analysis
不详
EJC SUPPLEMENTS, 2006, 4 (02): : 143 - 143
[37] Risks of triple negative breast cancer associated with cancer predisposition gene mutations.
Couch, Fergus J.
Akinhanmi, Margaret
Shimelis, Hermela
Hallberg, Emily J.
Hu, Chunling
Hart, Steven
Moore, Raymond
Meeks, Huong
Huether, Robert
Laduca, Holly
Chao, Elizabeth
Goldgar, David
Dolinsky, Jill S.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[38] c-kit gene mutations in adenoid cystic carcinoma are rare Response
Vila, Lizette
Liu, Hongyan
Al-Quran, Samer Z.
Coco, Dominique P.
Dong, Hui-Jia
Liu, Chen
MODERN PATHOLOGY, 2010, 23 (06) : 906 - 907
[39] The Frequency of Mutations in Exon 11 of the c-kit Gene in Patients With Leukemia
Hussain, Syed Rizwan
Babu, Sunil G.
Naqvi, Hena
Singh, Pradyumn
Mahdi, Farzana
TURKISH JOURNAL OF HEMATOLOGY, 2012, 29 (01) : 10 - 16
[40] Activating c-kit gene mutations in human germ cell tumors
Tian, QS
Frierson, HF
Krystal, GW
Moskaluk, CA
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (06): : 1643 - 1647

← 1 2 3 4 5 →